Murueta-Goyena, Ane http://orcid.org/0000-0002-9808-6943
Romero-Bascones, David
Teijeira-Portas, Sara
Urcola, J. Aritz
Ruiz-Martínez, Javier
Del Pino, Rocío http://orcid.org/0000-0002-6612-4757
Acera, Marian
Petzold, Axel http://orcid.org/0000-0002-0344-9749
Wagner, Siegfried Karl
Keane, Pearse Andrew
Ayala, Unai http://orcid.org/0000-0003-1079-752X
Barrenechea, Maitane http://orcid.org/0000-0003-0149-6944
Tijero, Beatriz
Gómez Esteban, Juan Carlos http://orcid.org/0000-0002-4697-3890
Gabilondo, Iñigo http://orcid.org/0000-0001-6045-2840
Funding for this research was provided by:
Osasun Saila, Eusko Jaurlaritzako (2019111100, 2020333033, 2022333011)
Article History
Received: 15 September 2023
Accepted: 8 January 2024
First Online: 23 January 2024
Competing interests
: Dr. Keane has acted as a consultant for Roche, Novartis, Boehringer-Ingleheim, Adecco, Bitfount and is an equity owner in Big Picture Medical. He has received speaker fees from Novartis, Gyroscope, Bayer, Thea, Boehringer-Ingleheim, Apellis, Abbvie, Alimera, Roche, Genentech, Specsavers, Heidelberg Engineering, Topcon, and Santen. He has received travel support from Bayer, Topcon, and Roche. He has attended advisory boards for Boehringer-Ingleheim, RetinAI, Novartis, Apellis, Abbvie, and Roche. He declares no non-financial competing interests. The remaining authors declare no competing interests.